PNC Financial Services Group Inc. Increases Stake in Astera Labs, Inc. $ALAB

PNC Financial Services Group Inc. lifted its position in Astera Labs, Inc. (NASDAQ:ALAB) by 40.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,375 shares of the company’s stock after acquiring an additional 2,107 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Astera Labs were worth $667,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Oliver Lagore Vanvalin Investment Group bought a new position in Astera Labs in the 2nd quarter valued at $29,000. Bernard Wealth Management Corp. purchased a new stake in shares of Astera Labs during the second quarter valued at $36,000. Harbour Investments Inc. grew its holdings in shares of Astera Labs by 351.7% in the first quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after purchasing an additional 619 shares during the last quarter. Ameritas Advisory Services LLC bought a new position in shares of Astera Labs in the second quarter worth about $64,000. Finally, National Bank of Canada FI increased its stake in Astera Labs by 112.4% in the 1st quarter. National Bank of Canada FI now owns 1,149 shares of the company’s stock worth $69,000 after buying an additional 608 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Astera Labs news, General Counsel Philip Mazzara sold 4,620 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $668,467.80. Following the completion of the sale, the general counsel directly owned 147,040 shares in the company, valued at $21,275,217.60. This trade represents a 3.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief executive officer directly owned 2,080,418 shares in the company, valued at $301,015,680.42. This represents a 4.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 619,436 shares of company stock worth $96,530,060. Insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 1.8%

Shares of NASDAQ:ALAB opened at $141.80 on Friday. The company has a market capitalization of $23.95 billion, a PE ratio of 127.75, a P/E/G ratio of 2.64 and a beta of 1.37. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The business’s fifty day simple moving average is $185.11 and its 200-day simple moving average is $146.27.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. During the same quarter last year, the company earned $0.23 earnings per share. The firm’s revenue for the quarter was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Ratings Changes

ALAB has been the subject of several research reports. Citigroup boosted their price objective on shares of Astera Labs from $160.00 to $275.00 and gave the company a “buy” rating in a research report on Wednesday, September 17th. CICC Research initiated coverage on shares of Astera Labs in a research note on Friday, August 29th. They set an “outperform” rating and a $190.00 price target for the company. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. TD Cowen dropped their price objective on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a research note on Wednesday, November 5th. Finally, Susquehanna raised their price objective on Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a report on Thursday, August 7th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $187.06.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.